Tenet eliminates poison pill, adopts governance changes

Dallas-based Tenet Healthcare announced March 5 that its board of directors has approved several changes to the company's corporate governance.

Here are five things to know about the changes.

1. The board approved changes to Tenet's bylaws that allow shareholders with a 25 percent stake in the company to request a special meeting. The move comes after the board approved amendments to the company's bylaws in January that allowed majority shareholders to request special meetings.

2. Tenet approved a short-term shareholder rights plan in August 2017, which was designed to protect $1.7 billion in net operating loss carryforwards and ensure the board could protect all shareholder interests as it executed CEO and board changes. Under the poison pill, if any person or entity acquired 4.9 percent or more of Tenet stock, all holders of rights issued under the plan are entitled to acquire shares of common stock with a 50 percent discount.

3. Tenet terminated the poison pill March 5. "The board made this decision based upon the reduced value of the NOL shareholder rights plan following recent tax law changes and an increase in the company's stock price since the NOL shareholder rights plan was adopted, as well as shareholder feedback," Tenet said in a statement. The poison pill was originally slated to expire following Tenet's 2018 annual meeting of stockholders, which is typically held in May.

4. Tenet announced March 5 that it also eliminated the executive committee as a standing committee of the company's board of directors.

5. "The board of directors and management have spent considerable time in recent weeks engaging with shareholders representing a majority of our outstanding stock and we received constructive input regarding Tenet and our objective to lead with best corporate governance practices," said Ronald A. Rittenmeyer, executive chairman and CEO of Tenet. "We believe the actions which we are taking today demonstrate our continued commitment to being responsive in a timely manner to shareholder feedback and to implementing measures that increase transparency and accountability."

More articles on healthcare finance:

94-year-old California hospital on active earthquake fault to close: 6 things to know
CHS sees Q4 net loss widen to $2B
CommunityCare claims Oklahoma health system overbilled 34 patients by $400k

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars